United States Antimony Corp Stock Prediction and Forecast [UAMY]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 12 Mar 2026, 04:32 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:24 UTC
![Video preview for United States Antimony Corp Stock Prediction and Forecast [UAMY]](https://i.ytimg.com/vi/gyZlmTBi7Eg/hqdefault.jpg)
AI-generated source summary
United States Antimony Corp (UAMY) stock is showing bullish signals from both short-term and long-term moving averages, with the short-term average above the long-term average. Technical indicators suggest a positive outlook, with a potential upside of approximately 49.37% over the next three months and a longer-term projection of 61.78%. The stock has experienced low daily movements, indicating low risk and consistent upward trends. However, negative signals from MACD and a pivot top from one day ago suggest potential short-term fluctuations. Support is found at $9.65, and a break below this level could lead to further declines. The company's P/E ratio of -280.81 indicates negative earnings, and the overall risk is assessed as very low, with a buy rating from analysts.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
